Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi

suck pdf from helios

10.1016/j.jinf.2020.04.021

http://scihub22266oqcxt.onion/10.1016/j.jinf.2020.04.021
suck pdf from google scholar
32335169!7177098!32335169
unlimited free pdf from europmc32335169    free
PDF from PMC    free
html from PMC    free
PDF vom PMID32335169  :  Publisher
PDF vom PMID32335169

suck abstract from ncbi

pmid32335169
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis #MMPMID32335169
  • Zheng Z; Peng F; Xu B; Zhao J; Liu H; Peng J; Li Q; Jiang C; Zhou Y; Liu S; Ye C; Zhang P; Xing Y; Guo H; Tang W
  • J Infect 2020[Aug]; 81 (2): e16-e25 PMID32335169show ga
  • BACKGROUND: An epidemic of Coronavirus Disease 2019 (COVID-19) began in December 2019 and triggered a Public Health Emergency of International Concern (PHEIC). We aimed to find risk factors for the progression of COVID-19 to help reducing the risk of critical illness and death for clinical help. METHODS: The data of COVID-19 patients until March 20, 2020 were retrieved from four databases. We statistically analyzed the risk factors of critical/mortal and non-critical COVID-19 patients with meta-analysis. RESULTS: Thirteen studies were included in Meta-analysis, including a total number of 3027 patients with SARS-CoV-2 infection. Male, older than 65, and smoking were risk factors for disease progression in patients with COVID-19 (male: OR=1.76, 95% CI (1.41, 2.18), P < 0.00001; age over 65 years old: OR =6.06, 95% CI(3.98, 9.22), P < 0.00001; current smoking: OR =2.51, 95% CI(1.39, 3.32), P=0.0006). The proportion of underlying diseases such as hypertension, diabetes, cardiovascular disease, and respiratory disease were statistically significant higher in critical/mortal patients compared to the non-critical patients (diabetes: OR=3.68, 95% CI (2.68, 5.03), P < 0.00001; hypertension: OR=2.72, 95% CI (1.60,4.64), P=0.0002; cardiovascular disease: OR=5.19, 95% CI(3.25, 8.29), P < 0.00001; respiratory disease: OR=5.15, 95% CI(2.51, 10.57), P < 0.00001). Clinical manifestations such as fever, shortness of breath or dyspnea were associated with the progression of disease [fever: 0R=0.56, 95% CI (0.38, 0.82), P=0.003;shortness of breath or dyspnea: 0R=4.16, 95% CI (3.13, 5.53), P < 0.00001]. Laboratory examination such as aspartate amino transferase(AST) > 40U/L, creatinine(Cr) >/= 133mol/L, hypersensitive cardiac troponin I(hs-cTnI) > 28pg/mL, procalcitonin(PCT) > 0.5ng/mL, lactatede hydrogenase(LDH) > 245U/L, and D-dimer > 0.5mg/L predicted the deterioration of disease while white blood cells(WBC)<4x10(9)/L meant a better clinical status[AST > 40U/L:OR=4.00, 95% CI (2.46, 6.52), P < 0.00001; Cr >/= 133mumol/L: OR=5.30, 95% CI (2.19, 12.83), P=0.0002; hs-cTnI > 28 pg/mL: OR=43.24, 95% CI (9.92, 188.49), P < 0.00001; PCT > 0.5 ng/mL: OR=43.24, 95% CI (9.92, 188.49), P < 0.00001;LDH > 245U/L: OR=43.24, 95% CI (9.92, 188.49), P < 0.00001; D-dimer > 0.5mg/L: OR=43.24, 95% CI (9.92, 188.49), P < 0.00001; WBC < 4x10(9)/L: OR=0.30, 95% CI (0.17, 0.51), P < 0.00001]. CONCLUSION: Male, aged over 65, smoking patients might face a greater risk of developing into the critical or mortal condition and the comorbidities such as hypertension, diabetes, cardiovascular disease, and respiratory diseases could also greatly affect the prognosis of the COVID-19. Clinical manifestation such as fever, shortness of breath or dyspnea and laboratory examination such as WBC, AST, Cr, PCT, LDH, hs-cTnI and D-dimer could imply the progression of COVID-19.
  • |Acute Disease[MESH]
  • |Adult[MESH]
  • |Age Factors[MESH]
  • |Aged[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/etiology/*mortality/pathology[MESH]
  • |Disease Progression[MESH]
  • |Female[MESH]
  • |Humans[MESH]
  • |Male[MESH]
  • |Middle Aged[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/etiology/*mortality/pathology[MESH]
  • |Risk Factors[MESH]
  • |Severity of Illness Index[MESH]
  • |Sex Factors[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    e16 2.81 2020